McKesson 5-year return hits 34.23%, beating market by 22.21%

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • McKesson achieved a 34.23% average annual return over the last five years
  • The stock outperformed the market by 22.21% on an annualized basis
  • A $100 investment made five years ago is now worth $431.70
  • Current market capitalization stands at $102.91 billion
powered bylight_fuzz_icon
51813652

*this image is generated using AI for illustrative purposes only.

McKesson Corporation (NYSE: MCK) has produced an average annual return of 34.23% over the past five years, outperforming the broader market by 22.21% on an annualized basis.

Currently, McKesson holds a market capitalization of $102.91 billion. The stock price stood at $882.70 at the time of writing, reflecting significant value accumulation for long-term holders.

Long-term compounding impact

The performance data illustrates the power of compounded returns in equity investments. An investor who had bought $100 worth of MCK stock five years ago would see that investment valued at $431.70 today. This growth highlights how sustained annual returns can multiply initial capital significantly over a medium-term horizon.

Key performance metrics

Metric Value
Average Annual Return (5 Years) 34.23%
Market Outperformance (Annualized) 22.21%
Current Market Cap $102.91 billion
Current Stock Price $882.70
Value of $100 Investment (5 Years) $431.70

What the numbers show

The divergence between McKesson’s 34.23% average annual return and its 22.21% annualized outperformance against the market indicates that the benchmark index itself returned approximately 12.02% annually during this period. This suggests that while the broader market provided positive returns, McKesson’s specific performance contributed nearly triple the market’s rate, driving the substantial absolute gain from $100 to $431.70.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific operational drivers or acquisitions have primarily fueled McKesson's 34.23% average annual return over the last five years?

How might increasing regulatory scrutiny on pharmaceutical distribution and pricing impact McKesson's ability to sustain its current outperformance?

Given the $102.91 billion market cap, what valuation multiples is McKesson currently trading at compared to its historical averages and peers like Cardinal Health?

like17
dislike

McKesson stock returns 34.83% annually over past five years

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • McKesson stock returned 34.83% annually over the past five years
  • The company outperformed the market by 23.05% on an annualized basis
  • A $100 investment made five years ago is now worth $433.00
  • Current market capitalization stands at $104.88 billion
powered bylight_fuzz_icon
51053041

*this image is generated using AI for illustrative purposes only.

McKesson (NYSE: MCK) has delivered an average annual return of 34.83% over the last five years, significantly outperforming the broader market.

The healthcare services company’s shares have appreciated by 23.05% on an annualized basis relative to the market benchmark during this period. As of the time of writing, McKesson trades at a price of $899.56, reflecting a total market capitalization of $104.88 billion.

Investment Growth Illustration

To contextualize the magnitude of these returns, an investor who purchased $100 worth of McKesson stock five years ago would see that position grow to $433.00 today. This transformation underscores the impact of sustained capital appreciation over a multi-year horizon.

Metric Value
Average Annual Return 34.83%
Market Outperformance 23.05% (annualized)
Current Share Price $899.56
Market Capitalization $104.88 billion

What the Numbers Show

The divergence between the average annual return and the market outperformance figure reveals the baseline performance of the broader market. With McKesson returning 34.83% and outperforming the market by 23.05%, the implied annualized market return over this period was approximately 11.78%. This indicates that while the market delivered positive growth, McKesson’s performance was driven by factors specific to the company or its sector, rather than general market tailwinds alone.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Can McKesson sustain its 34.83% annualized growth rate given its current $104.88 billion market capitalization and the law of large numbers?

How might increasing regulatory scrutiny on pharmaceutical distribution margins impact McKesson's future profitability compared to its historical performance?

What specific strategic initiatives or acquisitions are driving the company's significant outperformance relative to the broader healthcare sector?

like18
dislike

More News on McKesson Corp